A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

741

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

April 23, 2019

Study Completion Date

April 23, 2019

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-126 Gel

Gel

DRUG

IDP-126 Component A

Component A

DRUG

IDP-126 Component B

Component B

DRUG

IDP-126 Component C

Component C

DRUG

IDP-126 Vehicle Gel

Vehicle Gel

Trial Locations (34)

10022

Valeant Site 27, New York

10075

Valeant Site 26, New York

20769

valeant Site 21, Glenn Dale

23502

Valeant Site 35, Norfolk

27262

Valeant Site 23, High Point

30060

Valeant Site 15, Marietta

30078

Valeant Site 14, Snellville

32771

Valeant Site 12, Sanford

33162

Valeant Site 13, North Miami Beach

33401

Valeant Site 10, West Palm Beach

33437

Valeant Site 11, Boynton Beach

37215

Valeant Site 31, Nashville

40217

Valeant Site 18, Louisville

40241

Valeant Site 19, Louisville

48202

Valeant Site 22, Detroit

66215

Valeant Site 17, Overland Park

71913

Valeant Site 02, Hot Springs

78213

valeant Site 34, San Antonio

78660

Valeant Site 33, Pflugerville

78759

Valeant Site 32, Austin

80220

Valeant Site 09, Denver

83704

Valeant Site 16, Boise

87106

Valeant Site 25, Albuquerque

94538

Valeant Site 07, Fremont

95819

Valeant Site 08, Sacramento

97030

Valeant Site 28, Gresham

02492

Valeant Site 20, Needham

07960

Valeant Site 24, Morristown

02919

Valeant Site 30, Johnston

R3M 3Z4

Valeant Site 01, Winnipeg

L4M7G1

Valeant Site 05, Barrie

L6J7W5

Valeant Site 06, Oakville

K9J5K2

Valeant Site 04, Peterborough

N2J1C4

Valeant Site 03, Waterloo

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT03170388 - A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter